Development of a Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients
Observational Model: Case Control, Time Perspective: Prospective
Assessment of the slope of terminal D-3MH/3MH decay curve post-dosing.
Assess the slope of the terminal D-3MH/3MH decay curve for the post-dosing time period as calculated using plasma or urine samples and after a meat-containing or meat-free test meal.
Post-dosing 12 to 22 hours
Melinda Sheffield-Moore, Ph.D.
University of Texas
United States: Institutional Review Board
|University of Texas Medical Branch||Galveston, Texas 77555-1329|